How the pill became a lifestyle drug: the pharmaceutical industry and birth control in the United States since 1960.
Marketing decisions, rather than scientific innovations, have guided the development and positioning of contraceptive products in recent years. I review the stalled progress in contraceptive development in the decades following the advent of the Pill in 1960 and then examine the fine-tuning of the market for oral contraceptives in the 1990s and 2000s. Although birth control has been pitched in the United States as an individual solution, rather than a public health strategy, the purpose of oral contraceptives was understood by manufacturers, physicians, and consumers to be the prevention of pregnancy, a basic health care need for women. Since 1990, the content of that message has changed, reflecting a shift in the drug industry's view of the contraception business. Two factors contributed to bring about this change: first, the industry's move away from research and development in birth control and second, the growth of the class of medications known as lifestyle drugs.
Department of Anthropology, History, and Social Medicine at the University of California, San Francisco, CA 94143-0523, USA. elizabeth.watkins@ucsf.edu
Elizabeth Siegel
ES
Watkins
D003267:Contraception / Q000266:history*; D003276:Contraceptives, Oral / Q000266:history*; D004345:Drug Industry / Q000266:history*; D005260:Female; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D008019:Life Style / Q000266:history*; D040541:Marketing / Q000639:trends; D011247:Pregnancy; D012106:Research / Q000639:trends; D014481:United States
D003276:Contraceptives, Oral